31^st Annual European Pharma Congress April 28-29, 2021 London, UK

Biography:

Mohamed Raouf has completed his master degree in clinical pharmacy at the age of 35 years from Minia University. He is pharmacist I in medical critical care pharmacy of King Faisal Specialist Hospital and research center - Jeddah, KSA.

Abstract:

Background: Patients insufficient knowledge or misinformation about their medications may lead to poor treatment outcome. Inpatient pharmacist of KFSHRC-J developed a structured process to educate eligible patients in selected units about their newly prescribed medications (indications and side effects) during hospitalization.

 

Method: Daily report generated by pharmacy informatics for the newly prescribed medications in the selected units. Inpatient pharmacists are checking the daily reports and then reviewing patient’s profiles, followed by educating patients about their newly prescribed medication. Education is done through patient rooms extensions due to Covid 19 precautions. Pharmacist documented patient education through Microsoft form designed for this purpose. Inpatient pharmacist target to educate more than 50% of eligible inpatients about their newly started medication in selected units and more than 70% of eligible patients educated within 24 hours from starting new medication (to educate most of patients before discharge).

 

Results: On weekly basis data extracted from excel sheet generated by the Microsoft form, and analyzed to determine the percentage of educated patients. Percentage of educated eligible patients in selected units during September and October 2020 was 64 % (190 patients) educated for the newly prescribed medications. Percentage of patients received education within 24 hours of prescribing medications was 75% (142 patients).

Conclusion: inpatient education increase patient’s knowledge about their medications and compliance. Efforts will be continued by inpatient pharmacists and more resources will be allocated to expand for more units and to improve medication education service

Biography:

Cherif Chefchaouni Ali completed his studies in pharmacy this summer at the age of 26. He is currently resident in industrial pharmacy at the national institute of oncology. Prior to that, he was an intern for two years in the cardiovascular surgery department as a clinical pharmacist and in the hospital pharmacy department. He has currently published two articles in a scopus indexed journal.

 

Abstract:

Drug shortages have been a growing global problem in recent years. Some of them are of vital necessity and importance for the patient, such as those used to treat pathologies in clinical hematology and oncology departments. The objective of this study is to determine the impact of anti-cancer drugs shortages on the treatment and the patient and to describe the action to be taken that has been put in place to manage this shortage. It was a prospective, observational study, it took place in the oncology and hematology departments. It was carried out with the help of an operating sheet, which contained two parts: patient and treatment data. This sheet was filled out after the interview with the patient and on the basis of the medical file. Of the 101 patients interviewed, 67,3% were impacted by the shortage of drugs. The treated pathology that was most impacted by the rupture was Non-Hodgkin lymphoma (55,8%), vincristine was the drug most responsible for the shortages (34%). Most patients (51,4%) went to a non-local pharmacy to buy the medicine that was in short supply in the hospital. Delayed care was the main impact of the drug shortage (42,6%). As a result of these shortages, the majority of patients (45,6%) were frustrated and anxious about the situation. Drug shortages have a profound impact on patient safety, clinical outcomes, quality of treatment, hospital management and other important factors. In-depth collaboration between different health actors and timely communication strategies are essential elements of an effective drug shortage management plan.

 

Biography:

Cherif Chefchaouni Ali completed his studies in pharmacy this summer at the age of 26. He is currently resident in industrial pharmacy at the national institute of oncology. Prior to that, he was an intern for two years in the cardiovascular surgery department as a clinical pharmacist and in the hospital pharmacy department. He has currently published two articles in a scopus indexed journal.

 

Abstract:

Drug shortages have been a growing global problem in recent years. Some of them are of vital necessity and importance for the patient, such as those used to treat pathologies in clinical hematology and oncology departments. The objective of this study is to determine the impact of anti-cancer drugs shortages on the treatment and the patient and to describe the action to be taken that has been put in place to manage this shortage. It was a prospective, observational study, it took place in the oncology and hematology departments. It was carried out with the help of an operating sheet, which contained two parts: patient and treatment data. This sheet was filled out after the interview with the patient and on the basis of the medical file. Of the 101 patients interviewed, 67,3% were impacted by the shortage of drugs. The treated pathology that was most impacted by the rupture was Non-Hodgkin lymphoma (55,8%), vincristine was the drug most responsible for the shortages (34%). Most patients (51,4%) went to a non-local pharmacy to buy the medicine that was in short supply in the hospital. Delayed care was the main impact of the drug shortage (42,6%). As a result of these shortages, the majority of patients (45,6%) were frustrated and anxious about the situation. Drug shortages have a profound impact on patient safety, clinical outcomes, quality of treatment, hospital management and other important factors. In-depth collaboration between different health actors and timely communication strategies are essential elements of an effective drug shortage management plan.

 

Biography:

Mohamed Raouf has completed his master degree in clinical pharmacy at the age of 35 years from Minia University. He is pharmacist I in medical critical care pharmacy of King Faisal Specialist Hospital and research center - Jeddah, KSA

Abstract:

Background: Patients insufficient knowledge or misinformation about their medications may lead to poor treatment outcome. Inpatient pharmacist of KFSHRC-J developed a structured process to educate eligible patients in selected units about their newly prescribed medications (indications and side effects) during hospitalization.

 

Method: Daily report generated by pharmacy informatics for the newly prescribed medications in the selected units. Inpatient pharmacists are checking the daily reports and then reviewing patient’s profiles, followed by educating patients about their newly prescribed medication. Education is done through patient rooms extensions due to Covid 19 precautions. Pharmacist documented patient education through Microsoft form designed for this purpose. Inpatient pharmacist target to educate more than 50% of eligible inpatients about their newly started medication in selected units and more than 70% of eligible patients educated within 24 hours from starting new medication (to educate most of patients before discharge).

 

Results: On weekly basis data extracted from excel sheet generated by the Microsoft form, and analyzed to determine the percentage of educated patients. Percentage of educated eligible patients in selected units during September and October 2020 was 64 % (190 patients) educated for the newly prescribed medications. Percentage of patients received education within 24 hours of prescribing medications was 75% (142 patients).

Conclusion: inpatient education increase patient’s knowledge about their medications and compliance. Efforts will be continued by inpatient pharmacists and more resources will be allocated to expand for more units and to improve medication education service.